Independent Association of Individual Lipid Abnormalities with Cardiovascular All-cause Mortality: A Prospective Cohort Study

被引:0
|
作者
Zheng, Wenxiao [1 ]
Zhang, Jiayue [2 ]
Huang, Ying [1 ]
Wang, Shuting [1 ]
Gao, Xiangyang [3 ]
Yang, Zhirong [4 ,5 ]
Zong, Yueqi [6 ]
Yang, Zuyao [1 ]
机构
[1] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China
[2] Macau Univ Sci & Technol, Fac Med, Taipa, Macau, Peoples R China
[3] Luohe Med Coll, Affiliated Hosp 2, Hlth Management Ctr, Luohe, Henan Province, Peoples R China
[4] Shenzhen Univ Adv Technol, Dept Computat Biol & Med Big Data, Shenzhen, Guangdong Provi, Peoples R China
[5] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Guangdong Provi, Peoples R China
[6] Chinese Univ Hong Kong, Dept Social Work, Shatin, Hong Kong, Peoples R China
关键词
Dyslipidemia; Lipid profile; Cardiovascular risk; Mortality; NHANES; DENSITY-LIPOPROTEIN CHOLESTEROL; HEART-DISEASE MORTALITY; LOW HDL CHOLESTEROL; 25-YEAR FOLLOW-UP; HIGH-RISK; SERUM-CHOLESTEROL; PLASMA; TERM; MEN; OUTCOMES;
D O I
10.1007/s40292-024-00694-6
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
IntroductionAbnormalities in total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG) are each associated with increased cardiovascular risk, after adjusting for non-lipid risk factors. However, whether and to what extent the association for each lipid measure is confounded by other lipid measures is less understood.AimThis study aims to investigate the association of each lipid measure with cardiovascular and all-cause mortality while precluding the confounding caused by abnormalities in other lipid measures.MethodsThe study utilized data from the third National Health and Nutrition Examination Survey (NHANES III, 1988-1994) and ten cycles of continuous NHANES (1999-2018). The study cohort included 23,761 participants who were 20 years or older, not pregnant, not receiving lipid-lowering treatment, and had complete data on all four lipid measures and mortality status. Participants were categorized into seven subgroups based on their lipid profiles. Kaplan-Meier survival curves and Cox proportional hazards models were used to examine the association between lipid abnormalities and mortality.ResultsDuring a median follow-up of 140 months, 5,003 participants (14.1%) died, with 1,665 deaths (4.2%) attributable to cardiovascular causes. Compared with the reference group in which the four lipid measures were all normal, the subgroups with isolated high TC, two to three lipid abnormalities, and four lipid abnormalities were associated with increased risks for both cardiovascular and all-cause mortality in univariate analysis. However, only those with isolated high TC (for cardiovascular mortality, HR 1.52, 95% CI 1.13-2.06) and four lipid abnormalities (for all-cause mortality, HR 1.34, 95% CI 1.04-1.72) remained statistically significant after adjusting for non-lipid risk factors. Of note, compared with the reference group, the profile of non-lipid risk factors was apparently less favorable in the subgroup with two to three lipid abnormalities but similar (and some factors even more favorable) in the subgroup with isolated high TC. When the lipid measures were analyzed as continuous variables, a U-shaped relationship between HDL-C and mortality risk was observed for both cardiovascular and all-cause mortality, and very low LDL-C level was associated with increased mortality risk. No statistically significant association was found between TG levels and mortality risk.ConclusionIsolated high TC, very low LDL-C, and concurrent abnormalities in all four lipid measures were associated with increased mortality risk, whereas isolated high TG was not. A U-shaped relationship may exist between HDL-C level and mortality. Overall, these findings underscore the need for integrated management of dyslipidemia that takes all four lipid measures as well as non-lipid cardiovascular risk factors into account, particularly for those with concurrent abnormalities in two or more lipid measures.
引用
收藏
页码:107 / 119
页数:13
相关论文
共 50 条
  • [41] NT-proBNP and All-Cause and Cardiovascular Mortality in US Adults: A Prospective Cohort Study
    Echouffo-Tcheugui, Justin B.
    Zhang, Sui
    Daya, Natalie
    McEvoy, John W.
    Tang, Olive
    Juraschek, Stephen P.
    Ndumele, Chiadi E.
    Coresh, Josef
    Christenson, Robert H.
    Selvin, Elizabeth
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (11):
  • [42] Cumulative Muscle Strength and Risk of Cardiovascular Disease and All-cause mortality: A Prospective Cohort Study
    Qiu, Shanhu
    Wang, Qianqian
    Chen, Wenji
    Xie, Bo
    Wang, Duolao
    Cai, Xue
    Sun, Zilin
    Wu, Tongzhi
    ARCHIVES OF MEDICAL RESEARCH, 2023, 54 (03) : 261 - 269
  • [43] Cholesterol efflux capacity is an independent predictor of all-cause and cardiovascular mortality in patients with coronary artery disease: A prospective cohort study
    Liu, Chaoqun
    Zhang, Yuan
    Ding, Ding
    Li, Xinrui
    Yang, Yunou
    Li, Qing
    Zheng, Yuanzhu
    Wang, Dongliang
    Ling, Wenhua
    ATHEROSCLEROSIS, 2016, 249 : 116 - 124
  • [44] Association of glycation gap with all-cause and cardiovascular mortality in US adults: A nationwide cohort study
    Gu, Lingfeng
    Wang, Sibo
    Du, Chong
    Deng, Bo
    Ma, Yao
    Yang, Tongtong
    Shan, Tiankai
    Sun, Jiateng
    Wang, Hao
    Wang, Liansheng
    DIABETES OBESITY & METABOLISM, 2023, 25 (08): : 2073 - 2083
  • [45] Yoga participation and all-cause mortality: National prospective cohort study
    Loprinzi, Paul D.
    COMPLEMENTARY THERAPIES IN MEDICINE, 2015, 23 (06) : 757 - 758
  • [46] Outcome of the sertindole cohort prospective (SCoP) study: all-cause mortality
    Peuskens, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S404 - S405
  • [47] OUTCOME OF THE SERTINDOLE COHORT PROSPECTIVE(SCOP) STUDY: ALL-CAUSE MORTALITY
    Peuskens, Joseph
    Tanghoj, P.
    Mittoux, A.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 347 - 347
  • [48] Irregular sleep and all-cause mortality: A large prospective cohort study
    Omichi, Chie
    Koyama, Teruhide
    Kadotani, Hiroshi
    Ozaki, Etsuko
    Tomida, Satomi
    Yoshida, Tamami
    Otonari, Jun
    Ikezaki, Hiroaki
    Hara, Megumi
    Tanaka, Keitaro
    Tamura, Takashi
    Nagayoshi, Mako
    Okada, Rieko
    Kubo, Yoko
    Oze, Isao
    Matsuo, Keitaro
    Nakamura, Yohko
    Kusakabe, Miho
    Ibusuki, Rie
    Shibuya, Kenichi
    Suzuki, Sadao
    Watanabe, Miki
    Kuriki, Kiyonori
    Takashima, Naoyuki
    Kadota, Aya
    Katsuura-Kamano, Sakurako
    Arisawa, Kokichi
    Takeuchi, Kenji
    Wakai, Kenji
    SLEEP HEALTH, 2022, 8 (06) : 678 - 683
  • [49] Association of healthy sleep pattern with the risk of cardiovascular disease and all-cause mortality among people with diabetes: A prospective cohort study
    Li, Jing
    Yin, Jinghua
    Luo, Yi
    Ma, Tianqi
    He, Lingfang
    Xie, Hejian
    Li, Jinchen
    Zhang, Guogang
    Cheng, Xunjie
    Bai, Yongping
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [50] Association of Major Dietary Protein Sources With All-Cause and Cause-Specific Mortality: Prospective Cohort Study
    Sun, Yangbo
    Liu, Buyun
    Snetselaar, Linda G.
    Wallace, Robert B.
    Shadyab, Aladdin H.
    Kroenke, Candyce H.
    Haring, Bernhard
    Howard, Barbara, V
    Shikany, James M.
    Valdiviezo, Carolina
    Bao, Wei
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (05): : 1 - 24